Highly Leveraged ARCA Biotechnology Companies

Total Debt
Total DebtEfficiencyMarket RiskExp Return
1AMGN Amgen Inc
60.1 B
 0.18 
 1.53 
 0.28 
2BIIB Biogen Inc
6.63 B
(0.05)
 1.75 
(0.09)
3GILD Gilead Sciences
3.11 B
 0.16 
 1.59 
 0.25 
4EXAS EXACT Sciences
2.75 B
(0.15)
 2.54 
(0.38)
5REGN Regeneron Pharmaceuticals
2.7 B
(0.07)
 2.08 
(0.15)
6ILMN Illumina
2.54 B
(0.28)
 2.75 
(0.78)
7BRKR Bruker
2.21 B
(0.18)
 2.59 
(0.45)
8MTD Mettler Toledo International
2.01 B
(0.03)
 1.61 
(0.05)
9VRTX Vertex Pharmaceuticals
1.75 B
 0.23 
 1.52 
 0.35 
10WAT Waters
1.7 B
(0.01)
 1.84 
(0.01)
11HALO Halozyme Therapeutics
1.51 B
 0.33 
 1.46 
 0.48 
12SRPT Sarepta Therapeutics
1.33 B
(0.17)
 4.42 
(0.74)
13ALNY Alnylam Pharmaceuticals
1.3 B
 0.08 
 3.04 
 0.25 
14GMAB Genmab AS
1.03 B
(0.03)
 2.80 
(0.08)
15MRNA Moderna
710 M
(0.05)
 5.40 
(0.26)
16RGEN Repligen
686.25 M
(0.01)
 3.17 
(0.02)
17BMRN Biomarin Pharmaceutical
602.71 M
 0.08 
 1.65 
 0.12 
18NBIX Neurocrine Biosciences
455.1 M
(0.09)
 2.85 
(0.26)
19UTHR United Therapeutics
300 M
(0.09)
 2.32 
(0.22)
20BNTX BioNTech SE
254.2 M
(0.07)
 3.29 
(0.23)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.